Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx ingredients found in U.K. herbal

This article was originally published in The Tan Sheet

Executive Summary

The Medicines and Healthcare products Regulatory Agency seizes a traditional Chinese medicinal product sold in the U.K., Jia Yi Jian, after the product tested positive for high levels of prescription-only ingredients. The agency said April 7 that the adulterated product "presents a clear risk to consumers" by using natural ingredient claims to distract from what are likely "very low manufacturing and ethical standards." Lab testing showed Jia Yi Jian, manufactured by Hu Nan Aimin Pharmaceuticals, contains more than twice the legal dosage of the erectile dysfunction drug tadalafil, the active ingredient in Lilly's prescription Cialis, and more than four times the legal dosage of the obesity drug sibutramine, the active ingredient in Abbott's prescription Meridia

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102810

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel